Latest topics page 51
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 51 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cold packs, phase-change material, and what survives ten days — does this still hold?
Asking directly, because I could not find a straight answer: Cold packs, phase-change material, and what survives ten days — does this still hold? I have spent a fortnight trying to pin Cold packs down and I…
|
2 | 22k | 22mo | |
|
Hoarding and why it makes a shortage worse
Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
2 | 12k | 22mo | |
|
Revisiting: US compounding rules and how they changed
On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Regional question, dated February 2026, because everything in this category expires.…
|
+5 | 9 | 26k | 23mo |
|
How to ask for a dose change without antagonising anyone
The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. A question about how to describe something to a…
|
+19 | 23 | 2.9k | 23mo |
|
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+19 | 23 | 62k | 23mo |
|
A rising related-substance total over six months: degradation or method drift?
Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Rising related-substance — I have the observation and I do not trust…
|
+37 | 42 | 37k | 23mo |
|
Orforglipron as a non-peptide: what changes when the molecule is small
On the subject in the title: Orforglipron as a non-peptide: what changes when the molecule is small Working notes rather than a conclusion. What changes if the standard account of orforglipron is wrong? I ask…
|
+26 | 30 | 26k | 23mo |
|
Reading a meta-analysis you disagree with, fairly
Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I would like to disagree carefully with the settled view on reading a…
|
+7 | 13 | 2.5k | 23mo |
|
Circumference measurements as a poor man's composition estimate
Posting this under the heading it deserves: Circumference measurements as a poor man's composition estimate Everything below is what sits behind that. Working notes on circumference measurements rather than a…
|
+96 | 112 | 14k | 23mo |
|
Correlation in a self-tracked dataset: what it can support
Correlation in a self-tracked dataset: what it can support — setting out what I have, and where I think it stops being reliable. Posting a small dataset on correlation. It is mine, it is uncontrolled, and the…
|
+152 | 166 | 48k | 23mo |
|
Follow-up: A partial dose because the pen emptied mid-injection
Posting this under the heading it deserves: A partial dose because the pen emptied mid-injection Everything below is what sits behind that. A follow-up question about partial dose because the pen that I did…
|
+10 | 14 | 10k | 23mo |
|
Chronic kidney disease and the FLOW result
Posting this under the heading it deserves: Chronic kidney disease and the FLOW result Everything below is what sits behind that. Chronic kidney disease: setting out the arithmetic in full, because I have had…
|
+34 | 38 | 33k | 23mo |
|
High-resolution MS on aggregates and what it can see — one year on
High-resolution MS on aggregates and what it can see — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about High-resolution, deliberately…
|
+54 | 58 | 1.2k | 23mo |
|
Coming back to: Purity assay versus content assay: two different numbers
Purity assay versus content assay: two different numbers — setting out what I have, and where I think it stops being reliable. Asking about Purity assay versus content assay directly, because I have read four…
|
+71 | 77 | 31k | 23mo |
|
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
|
2 | 49k | 2y | |
|
Coming back to: Pricing far outside the range, in either direction
Pricing far outside the range, in either direction Writing it up because I had to work it out twice and would rather nobody else did. Pricing far outside the range — I have the observation and I do not trust…
|
+22 | 26 | 325 | 2y |
|
Naming conventions for research peptides and the confusion they cause — one year on
Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. Asking about Naming conventions for research peptides…
|
+1 | 5 | 181 | 2y |
|
[2026 update] Request: show the solution author in the topic list
Request: show the solution author in the topic list Writing it up because I had to work it out twice and would rather nobody else did. Bringing the figures rather than the impression, since a process question…
|
2 | 59 | 2y | |
|
Mean kinetic temperature explained without the mathematics
Posting this under the heading it deserves: Mean kinetic temperature explained without the mathematics Everything below is what sits behind that. Two things I would like separated before anyone answers on…
|
2 | 1.5k | 2y | |
|
The mass-error checker and its intended scope
The mass-error checker and its intended scope Writing it up because I had to work it out twice and would rather nobody else did. Proposing that mass-error checker deserves a maintained page rather than a…
|
+149 | 167 | 42k | 2y |
|
Second pass at: Journal club: LEADER as the historical anchor
Posting this under the heading it deserves: Second pass at: Journal club: LEADER as the historical anchor Everything below is what sits behind that. Two things I would like separated before anyone answers on…
|
+75 | 81 | 2k | 2y |
|
Guidelines revision: what changed and why
Guidelines revision: what changed and why Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about guidelines revision in a thread last spring and I would like to…
|
+125 | 142 | 1.7k | 2y |
|
How this community labels and discusses unrefereed work
How this community labels and discusses unrefereed work — that is the question, and I have not found it answered plainly anywhere I have looked. Reading an unrefereed manuscript properly, and asking whether I…
|
+112 | 119 | 1.3k | 2y |
|
Follow-up: Conditions that change the calculus rather than forbidding it
Posting this under the heading it deserves: Conditions that change the calculus rather than forbidding it Everything below is what sits behind that. I was wrong about Conditions in a thread last spring and I…
|
+30 | 34 | 62k | 2y |
|
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. Working notes on four-week escalation interval rather than a…
|
+56 | 60 | 21k | 2y |
|
Refrigerated versus room temperature: the trade-off stated plainly
Refrigerated versus room temperature: the trade-off stated plainly Writing it up because I had to work it out twice and would rather nobody else did. The question about refrigerated versus room temperature…
|
2 | 66k | 2y | |
|
Second pass at: Retatrutide dose escalation in the published trials
Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on Retatrutide…
|
+115 | 125 | 30k | 2y |
|
Cold packs, phase-change material, and what survives ten days
Cold packs, phase-change material, and what survives ten days — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin cold packs down and I want to set out…
|
+132 | 138 | 65k | 2y |
|
Oral contraceptives and delayed emptying: what the data shows
Posting this under the heading it deserves: Oral contraceptives and delayed emptying: what the data shows Everything below is what sits behind that. The question about oral contraceptives and delayed emptying…
|
+63 | 71 | 5.9k | 2y |
|
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Reading FLOW ( N Engl J Med , 2024) for the population rather than the…
|
+84 | 91 | 18k | 2y |